Header Logo

Connection

Christopher Graffeo to Bevacizumab

Back to Details
This is a "connection" page, showing publications Christopher Graffeo has written about Bevacizumab.
Christopher Graffeo
Connection Strength
0.160
Bevacizumab
  1. Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J Neurooncol. 2019 Sep; 144(2):239-248.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.